Viewing nowYuyu Cefaclor Capsule (Cefaclor Hydrate)
Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

MFDS item code 201207573 · Approved 2012.10.31 · Insurance code 644501880
Treatment of otitis media, respiratory infections (pneumonia, pharyngitis, etc.), and urinary tract infections (pyelonephritis, cystitis, etc.)
This medication is used to treat various infectious diseases. It is effective against respiratory infections such as otitis media, pneumonia, pharyngitis, tonsillitis, and bronchitis, and is also used for the treatment of urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. Moreover, it is suitable for treating skin and soft tissue infections such as boils, abscesses, folliculitis, soft tissue inflammation, infectious granulomas, subcutaneous abscesses, infected wounds, and wound infections. The major causative bacteria include Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella, and Neisseria gonorrhoeae. This medication is effectively used to treat various bacterial infections.
For cefaclor hydrate, administer 250mg (potency) every 8 hours orally. In the case of severe infections (such as pneumonia) and infections with low sensitivity, the dose may be doubled. For acute gonococcal urethritis, administer 3g of this medication in a one-time combination with 1g of probenecid.
Administer 20mg (potency) per Kg of body weight every 8 hours. In the case of severe infections, otitis media, and infections with low sensitivity, a dose of 40mg (potency) per Kg of body weight may be given, with a maximum dose of
This medication works by binding to specific proteins and interfering with bacterial cell wall synthesis, thereby killing bacteria. This medication should not be used in patients who have previously experienced shock due to this medication or have had allergic reactions to this medication or cephalosporin antibiotics. Additionally, as it contains lactose, patients with lactose intolerance or genetic lactose metabolism disorders should not take this medication. Patients with a history of allergy to penicillin or atopy, severe renal impairment, difficulty in oral intake, the elderly, or those in poor general condition need caution while using this medication, and may show symptoms of vitamin K deficiency, hence close monitoring is necessary. Patients with a history of gastrointestinal diseases, especially those who have had colitis, should also be administered with caution. This medication may rarely cause shock or severe allergic reactions, so abnormal symptoms should be closely monitored during administration, and if serious rashes or ulcers occur on the skin, administration should be stopped immediately. Blood cell counts may show abnormalities, so regular blood tests are necessary to monitor the condition, as it can also affect liver or kidney functions. Gastrointestinal side effects such as diarrhea, abdominal pain, and nausea may occur, and sometimes severe colitis may develop, so immediate consultation with a physician is required if symptoms appear. Respiratory and central nervous system symptoms may also rarely occur, so they should be reported immediately if they occur. This medication may cause dysbiosis such as stomatitis or candidiasis, and symptoms of vitamin K or vitamin B deficiency may also rarely occur. It is important to perform susceptibility testing to prevent the emergence of resistant strains and to administer for only the necessary duration. Interactions with other medications should be noted, especially when used with medications affecting the kidneys, anticoagulants, or oral contraceptives, and should be used according to a physician's directives. Pregnant or breastfeeding women should use this medication cautiously, as its safety has not been fully established. Safety in neonates under one month has not been established. The elderly may show abnormal reactions easily due to decreased physiological functions and are at risk of bleeding; therefore, dosage and intervals should be adjusted, and they should be monitored closely. This medication may affect some clinical test results, so it is advisable to inform the healthcare professional when undergoing tests.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a tightly sealed container that blocks light. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will ensure the effectiveness of the medication.
A purple opaque hard capsule with a light yellow powder inside, opaque white at the bottom.
30 capsules/bottle, 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCefaclor Hydrate 250mg
Hard capsule · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.